Catalyst Private Wealth’s First Trust NYSE Arca Biotechnology Index Fund FBT Stock Holding History

Catalyst Private Wealth’s Portfolio FBT Stock Details FBT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$212K	Buy	+778	New	+$202K	0.09%	100

Other funds holding FBT

TD Waterhouse Canada Toronto, Ontario, Canada $38.4B AUM 30.28% 1-Year Est. Return

Arlington Financial Advisors Santa Barbara, California $796M AUM 16.35% 1-Year Est. Return

B. Riley Wealth Advisors Boca Raton, Florida $2.57B AUM 28.13% 1-Year Est. Return

Concurrent Investment Advisors Tampa, Florida $14.5B AUM 24.52% 1-Year Est. Return

Farther Finance Advisors San Francisco, California $14.2B AUM 18.33% 1-Year Est. Return

JWS

Juncture Wealth Strategies Scottsdale, Arizona $390M AUM 19.15% 1-Year Est. Return

TWM

TriaGen Wealth Management Calabasas, California $413M AUM 35.91% 1-Year Est. Return

QCIG

Quad-Cities Investment Group Davenport, Iowa $280M AUM 15.19% 1-Year Est. Return

IFP Advisors Tampa, Florida $5.86B AUM 20.09% 1-Year Est. Return

Wealth Enhancement Advisory Services Plymouth, Minnesota $67.3B AUM 21.9% 1-Year Est. Return

Catalyst Private Wealth's FBT Position: Q3 2026 in Review

Catalyst Private Wealth opened a new position in First Trust NYSE Arca Biotechnology Index Fund (FBT) in Q3 2026: 778 shares worth $212K. The stake represents 0.09% of the portfolio and ranks #100 among its holdings.

65 funds tracked by Wall St. Rank hold FBT as of Q3 2026.

Catalyst Private Wealth held 778 shares of First Trust NYSE Arca Biotechnology Index Fund worth $212K as of Q3 2026.
First Trust NYSE Arca Biotechnology Index Fund was a new Catalyst Private Wealth position in Q3 2026.
First Trust NYSE Arca Biotechnology Index Fund made up 0.09% of Catalyst Private Wealth's portfolio in Q3 2026, its #100 holding.
65 funds tracked by Wall St. Rank held First Trust NYSE Arca Biotechnology Index Fund as of Q3 2026.

Based on Catalyst Private Wealth's 13F filing for Q3 2026, filed 13 Oct 2026.